Cargando…

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

OBJECTIVE: To accurately evaluate tumor heterogeneity, make multidimensional diagnosis according to the causes and phenotypes of tumor heterogeneity, and assist in the individualized treatment of tumors. BACKGROUND: Tumor heterogeneity is one of the most essential characteristics of malignant tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Liang, Jiang, Minlin, Wang, Hao, Sun, Hui, Zhu, Jun, Zhao, Wencheng, Fang, Qiyu, Yu, Jia, Chen, Peixin, Wu, Shengyu, Zheng, Zixuan, He, Yayi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422119/ https://www.ncbi.nlm.nih.gov/pubmed/34532488 http://dx.doi.org/10.21037/atm-21-1948

Ejemplares similares

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
por: Jiang, Minlin, et al.
Publicado: (2021)

Risk-score model to predict prognosis of malignant airway obstruction after interventional bronchoscopy
por: Jiang, Minlin, et al.
Publicado: (2021)

The application of artificial intelligence in lung cancer: a narrative review
por: Zhang, Huixian, et al.
Publicado: (2021)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research
por: Wang, Hao, et al.
Publicado: (2021)

Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
por: Zhu, Kaibo, et al.
Publicado: (2021)

The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
por: Liu, Yu, et al.
Publicado: (2021)

Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Guo, Haoyue, et al.
Publicado: (2021)

Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review
por: Cai, Yiyi, et al.
Publicado: (2021)

Current progress and mechanisms of bone metastasis in lung cancer: a narrative review
por: Wu, Shengyu, et al.
Publicado: (2021)

Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment
por: Zhu, Liang, et al.
Publicado: (2022)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19
por: Guo, Haoyue, et al.
Publicado: (2020)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2023)

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
por: Wu, Fengying, et al.
Publicado: (2021)

mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer
por: Chen, Peixin, et al.
Publicado: (2021)

cGAS-STING, an important pathway in cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2020)

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
por: Zhang, Aiping, et al.
Publicado: (2022)

Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
por: Gao, Jian-Peng, et al.
Publicado: (2018)

The anti-tumor potential of sinomenine: a narrative review
por: Zhu, Jun, et al.
Publicado: (2023)

Heterogeneity of the tumor immune microenvironment and its clinical relevance
por: Jia, Qingzhu, et al.
Publicado: (2022)

The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review
por: Song, Xinyu, et al.
Publicado: (2021)

Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases
por: Guo, Yiying, et al.
Publicado: (2023)

Heterogeneous Myeloid Cells in Tumors
por: Dou, Aixia, et al.
Publicado: (2021)

Challenges and strategies of clinical application of CAR-T therapy in the treatment of tumors—a narrative review
por: Li, Weijing, et al.
Publicado: (2020)

Comparison of the next-generation sequencing (NGS) technology with culture methods in the diagnosis of bacterial and fungal infections
por: Chen, Peixin, et al.
Publicado: (2020)

Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis
por: Chen, Peixin, et al.
Publicado: (2020)

Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
por: Schmidt, Felix, et al.
Publicado: (2016)

Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance
por: He, Lin-feng, et al.
Publicado: (2023)

Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index
por: Hu, Nan, et al.
Publicado: (2021)

A narrative review of chimeric antigen receptor-T (CAR-T) cell therapy for lung cancer
por: Liu, Yujia, et al.
Publicado: (2021)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells
por: Dai, Zhe, et al.
Publicado: (2020)

ecDNA within tumors: a new mechanism that drives tumor heterogeneity and drug resistance
por: Zeng, Xixi, et al.
Publicado: (2020)

Advances in the Application of Apoptotic Proteins and Alternative Splicing in Tumor Therapy: A Narrative Review
por: He, Jin, et al.
Publicado: (2023)

Editorial: Tumor Heterogeneity
por: La Rosa, Stefano, et al.
Publicado: (2019)

Integrated Analysis of Tumor Samples Sheds Light on Tumor Heterogeneity
por: Parisi, Fabio, et al.
Publicado: (2012)

Ovarian Cancer Molecular Stratification and Tumor Heterogeneity: A Necessity and a Challenge
por: Symeonides, Stefan, et al.
Publicado: (2015)

Local and systemic inflammation triggers different outcomes of tumor growth related to infiltration of anti-tumor or pro-tumor macrophages
por: Liu, Xinghan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oq324dtbp3ih9a7jhl46rgiuc0